ArticleBone marrow transplantation2015

Early recovery of CMV immunity after HLA-haploidentical hematopoietic stem cell transplantation as a surrogate biomarker for a reduced risk of severe infections overall.

M Noviello et al.PubMed ↗Publisher ↗

No numbers read from the abstract.